- 優先名称
- Cycloviracin B2
- IUPAC
- 3-[16,22-bis[[4,5-dihydroxy-6-(hydroxymethyl)-3-methoxyoxan-2-yl]oxy]tricosyl]-14-[14-[4,5-dihydroxy-6-(hydroxymethyl)-3-methoxyoxan-2-yl]oxy-20-oxohenicosyl]-9,10,11,20,21,22-hexahydroxy-2,6,13,17,23,24-hexaoxatricyclo[17.3.1.18,12]tetracosane-5,16-dione
- 現地名
- 3-[16,22-ビス[(2-O-メチル-β-D-グルコピラノシル)オキシ]トリコシル]-9,10,11,20,21,22-ヘキサヒドロキシ-14-[14-[(2-O-メチル-β-D-グルコピラノシル)オキシ]-20-オキソヘニコシル]-2,6,13,17,23,24-ヘキサオキサトリシクロ[17.3.1.18,12]テトラコサン-5,16-ジオン
- 英語名
- cycloviracin B2
- 分子式
- C83H150O33
- 分子量
- 1676.06
名称と別名
Cycloviracin B2Cycloviracin-B2142382-46-53-[16,22-bis[[4,5-dihydroxy-6-(hydroxymethyl)-3-methoxyoxan-2-yl]oxy]tricosyl]-14-[14-[4,5-dihydroxy-6-(hydroxymethyl)-3-methoxyoxan-2-yl]oxy-20-oxohenicosyl]-9,10,11,20,21,22-hexahydroxy-2,6,13,17,23,24-hexaoxatricyclo[17.3.1.18,12]tetracosane-5,16-dione3-(16,22-bis((4,5-dihydroxy-6-(hydroxymethyl)-3-methoxyoxan-2-yl)oxy)tricosyl)-14-(14-(4,5-dihydroxy-6-(hydroxymethyl)-3-methoxyoxan-2-yl)oxy-20-oxohenicosyl)-9,10,11,20,21,22-hexahydroxy-2,6,13,17,23,24-hexaoxatricyclo(17.3.1.18,12)tetracosane-5,16-dioneRefChem:1300482,6,13,17,23,24-Hexaoxatricyclo(17.3.1.1(8,12))tetracosane-5,16-dione, 3-(16,22-bis(2-O-methyl-beta-D-glucopyranosyl)oxy)tricosyl)-9,10,11,20,21,22-hexahydroxy-14-(14-(14-((2-O-methyl-beta-D-glucopyranosyl)oxy)-20-oxoheneicosyl)-orb3024583CHEBI:202116TN103383-[16,22-ビス[(2-O-メチル-β-D-グルコピラノシル)オキシ]トリコシル]-9,10,11,20,21,22-ヘキサヒドロキシ-14-[14-[(2-O-メチル-β-D-グルコピラノシル)オキシ]-20-オキソヘニコシル]-2,6,13,17,23,24-ヘキサオキサトリシクロ[17.3.1.18,12]テトラコサン-5,16-ジオン